- Home
- POLA vs KZIA Comparison
POLA vs KZIA Comparison
Compare POLA & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- KZIA
- Stock Information
- Founded
- POLA 1979
- KZIA 1994
- Country
- POLA United States
- KZIA Australia
- Employees
- POLA N/A
- KZIA N/A
- Industry
- POLA Industrial Machinery/Components
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- KZIA Health Care
- Exchange
- POLA Nasdaq
- KZIA Nasdaq
- Market Cap
- POLA 5.6M
- KZIA 5.1M
- IPO Year
- POLA 2016
- KZIA 1999
- Fundamental
- Price
- POLA $1.70
- KZIA $6.10
- Analyst Decision
- POLA
- KZIA Strong Buy
- Analyst Count
- POLA 0
- KZIA 2
- Target Price
- POLA N/A
- KZIA $57.50
- AVG Volume (30 Days)
- POLA 9.0K
- KZIA 2.6M
- Earning Date
- POLA 08-13-2025
- KZIA 07-07-2025
- Dividend Yield
- POLA N/A
- KZIA N/A
- EPS Growth
- POLA N/A
- KZIA N/A
- EPS
- POLA N/A
- KZIA N/A
- Revenue
- POLA $13,918,000.00
- KZIA $1,549,158.00
- Revenue This Year
- POLA N/A
- KZIA N/A
- Revenue Next Year
- POLA N/A
- KZIA N/A
- P/E Ratio
- POLA N/A
- KZIA N/A
- Revenue Growth
- POLA 8.08
- KZIA 248983.08
- 52 Week Low
- POLA $1.65
- KZIA $2.86
- 52 Week High
- POLA $4.90
- KZIA $79.00
- Technical
- Relative Strength Index (RSI)
- POLA 42.95
- KZIA 50.96
- Support Level
- POLA $1.67
- KZIA $5.83
- Resistance Level
- POLA $1.75
- KZIA $9.60
- Average True Range (ATR)
- POLA 0.05
- KZIA 1.19
- MACD
- POLA 0.01
- KZIA -0.29
- Stochastic Oscillator
- POLA 57.14
- KZIA 18.39
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.